Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2021
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
GentaGel develops a local slow-release antibiotic treatment, which is injected and continuously releases antibiotics for up to 60 days. The antibiotic is not detectable in circulation but achieves sufficient therapeutic concentrations in the administered area. GentaGel provides an effective antibiotic treatment while avoiding systemic side-effects and expensive cost-of-care. The company is based on a ground-breaking drug delivery technology invented by Prof. Domb, for the in-situ sustained release of antibiotics for the treatment and prevention of surgical site infections.
Q&A
- What is GentaGel's primary focus?
- GentaGel develops a local slow-release antibiotic treatment designed to be injected and continuously release antibiotics for up to 60 days, aiming to treat and prevent surgical site infections.
- When was GentaGel founded?
- GentaGel was founded in July 2021.
- How many employees does GentaGel currently have?
- GentaGel has 6 employees, falling into the 1-10 employee bucket.
- What is GentaGel's current funding stage?
- GentaGel is currently in the Pre-Funding stage.
- Who is a co-founder of GentaGel?
- Abraham Domb is a co-founder of GentaGel and also the inventor of the drug delivery technology upon which the company is based.
- What sector does GentaGel primarily operate in?
- GentaGel's primary sector is Health Tech & Life Sciences, with additional classifications in Pharma & Medical Biotechnology, Drug Delivery, Medical Devices, and Medical Treatment & Therapeutics.
- What is the product stage of GentaGel's treatment?
- The product stage of GentaGel's treatment is clinical trial.
- Where is GentaGel headquartered?
- GentaGel is headquartered in Jerusalem, Israel.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProvidersMedical Devices IndustryMedical Products
Business model
B2C
Tags
polymersantibioticspharmaceuticalsinfection
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | gentagel-lr.com/ |
|---|
Identifiers & details
| Founded | 2021-7 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | gentagel-lr.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|